China Securities Co.Ltd(601066)
about
Tinavi Medical Technologies Co.Ltd(688277) issue shares to specific objects in 2021
And listed on the scientific innovation board
of
Issuance recommendation
Sponsor
December, 2001
Statement of recommendation institution and recommendation representative
China Securities Co.Ltd(601066) and sun Dong and Zhu Jin, the sponsor representatives of the project, are honest, trustworthy, diligent and responsible in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China and other relevant laws and regulations, the relevant provisions of the China Securities Regulatory Commission and the relevant business rules of Shanghai Stock Exchange The issuance recommendation letter is issued in accordance with the industry practice norms and ethical standards, and the authenticity, accuracy and completeness of the issuance recommendation letter are guaranteed.
catalogue
interpretation…… Section 1 basic information of this securities issuance 5 I. The sponsor representative specifically responsible for the recommendation of this securities issuance 5 II. The co sponsors of the securities issuance project and other members of the project team 5 III. basic information of the issuer 6 IV. description of the relationship between the sponsor and the issuer 11 v. internal audit procedures and core opinions of the recommendation institution Vi. verification of private investment fund filing by the sponsor Section II commitments of the sponsor Section III verification of paid employment of third-party institutions and individuals 16 I. verification of the sponsor’s paid employment of a third party and other related acts 16 II. Verification of the issuer’s paid employment of a third party and other related acts 16 Section IV recommendations for this offering 17 I. the decision-making procedure of the Issuer on this issuance is legal 17 II. This offering complies with relevant laws and regulations 18 III. main risk tips of the issuer 22 IV. evaluation on the development prospect of the issuer 28 v. recommendation conclusion of the recommendation institution on this securities issuance twenty-eight
interpretation
In this issuance recommendation letter, unless otherwise specified, the following words have the following specific meanings: recommendation institution, this recommendation institution, refers to China Securities Co.Ltd(601066) lead underwriter, China Securities Co.Ltd(601066) securities company, issuer, Tinavi Medical Technologies Co.Ltd(688277) refers to Tinavi Medical Technologies Co.Ltd(688277) controlling shareholder and actual controller
Company law means the company law of the people’s Republic of China
Securities Law means the securities law of the people’s Republic of China
General meeting means Tinavi Medical Technologies Co.Ltd(688277) general meeting of shareholders
Board of directors means the Tinavi Medical Technologies Co.Ltd(688277) board of directors
Board of supervisors means Tinavi Medical Technologies Co.Ltd(688277) the board of supervisors
CSRC refers to the China Securities Regulatory Commission
Shanghai stock exchange refers to Shanghai Stock Exchange
This securities issuance and this issuance refer to the issuance of shares to specific objects in Tinavi Medical Technologies Co.Ltd(688277) 2021
A shares and shares refer to RMB ordinary shares with a par value of RMB 1.00 per share issued by the company
Yuan means RMB yuan (except as specifically mentioned herein)
Pricing base date refers to the base date for calculating the issue reserve price
The State Drug Administration and nmpa refer to the State Drug Administration
The state health and family planning commission refers to the state health and Family Planning Commission of the people’s Republic of China
The measures for the administration of the registration of the science and Innovation Board refer to the measures for the administration of the registration of securities issuance of listed companies on the science and Innovation Board (Trial)
(row)
Mazor robotics refers to mazor robotics Ltd., an Israeli orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) manufacturer, which was later acquired by Medtronic
Mako surgical company refers to Mako surgical Corp., an American joint replacement Siasun Robot&Automation Co.Ltd(300024) manufacturer, which was later acquired by Stryker
MedTech company refers to MedTech S.A.S, a French surgical Siasun Robot&Automation Co.Ltd(300024) manufacturing enterprise, which was later acquired by Gemini bangmei
Medtronic Inc (Medtronic), founded in 1949, is headquartered in the United States, and is the world’s largest medical technology company Medtronic. It provides lifelong treatment for patients with chronic diseases, including cardiovascular group, restorative therapy group, minimally invasive treatment group and diabetes business group.
Stryker Corporation, founded in 1946 and headquartered in the United States, is one of the largest orthopedic and medical technology companies in the world, with 14 production, R & D and sales divisions around the world
Zimmer Biomet, founded in 1927 and headquartered in the United States, is committed to the design, R & D, manufacturing and marketing of orthopaedic reconstruction, spinal cord and trauma instruments, artificial dental implants and related surgical products
Xinjun refers to Shenzhen xinjunte Intelligent Medical Instrument Co., Ltd
Any discrepancy between the total number and the mantissa of the sum of the itemized values in this issuance recommendation letter shall be caused by rounding.
Section 1 basic information of this securities issuance
1、 The sponsor representative specifically responsible for the recommendation of this securities issuance
Sun Dong and Zhu Jin are designated by China Securities Co.Ltd(601066) securities as the sponsor representatives of this issuance to specific objects.
The practice of the above two sponsor representatives is as follows:
Mr. Sun Dong: sponsor representative, master’s degree, now director of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in: Daodaoquan Grain And Oil Co.Ltd(002852) initial public offering project, Zhuhai Winbase International Chemical Tank Terminal Co.Ltd(002492) initial public offering project, Yinbang Clad Material Co.Ltd(300337) initial public offering project, Tinavi Medical Technologies Co.Ltd(688277) initial public offering project, Liyuan refining non-public offering project, Hbis Company Limited(000709) share allotment project, Talkweb Information System Co.Ltd(002261) non-public offering project, Chongqing Sokon Industry Group Stock Co.Ltd(601127) convertible bond project, Sany Heavy Industry Co.Ltd(600031) M & a project and guochuang energy M & a project Zhuzhou Tianqiao Crane Co.Ltd(002523) M & A projects, CRRC industrial investment M & A projects, etc. During the practice of recommendation business, we strictly abide by the measures for the administration of securities issuance and listing recommendation business and other relevant provisions, and have a good practice record.
Mr. Zhu Jin: sponsor representative, master’s degree, now vice president of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in: Daodaoquan Grain And Oil Co.Ltd(002852) initial public offering project, Tinavi Medical Technologies Co.Ltd(688277) initial public offering project, Liyuan refining non-public offering project, Hbis Company Limited(000709) share allotment project, Talkweb Information System Co.Ltd(002261) non-public offering project, Ja Solar Technology Co.Ltd(002459) non-public offering project, Tianye Tonglian M & a project, Shandong Ruifeng Chemical Co.Ltd(300243) M & A project, etc. During the practice of recommendation business, we strictly abide by the measures for the administration of securities issuance and listing recommendation business and other relevant provisions, and have a good practice record. 2、 Co sponsors of this securities issuance project and other members of the project team (I) Co sponsors of this securities issuance project
The co sponsor of this securities issuance project is Li Jihua, and the implementation of its recommendation business is as follows:
Mr. Li Jihua, with a master’s degree, is now the senior vice president of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in: Daodaoquan Grain And Oil Co.Ltd(002852) initial public offering project, Sinosteel New Materials Co.Ltd(002057) non-public offering project, etc. During the practice of recommendation business, we strictly abide by the measures for the administration of securities issuance and listing recommendation business and other relevant provisions, and have a good practice record.
（2） Other members of the securities issuance project team
Other members of the securities issuance project team include Song Yang, Chen Yue, Zhou Zhenxiang and Jin Huaqiang.
Mr. Song Yang: sponsor representative, master degree, senior vice president of China Securities Co.Ltd(601066) securities investment banking department. He has presided over or participated in the following projects: Shenzhen Liande Automatic Equipment Co.Ltd(300545) initial public offering project, Hangzhou Freely Communication Co.Ltd(603602) initial public offering project, Gan & Lee Pharmaceuticals(603087) initial public offering project, Haichen logistics initial public offering project, Unilumin Group Co.Ltd(300232) non-public offering project, Beijing Forever Technology Co.Ltd(300365) non-public offering project, Talkweb Information System Co.Ltd(002261) non-public Development Bank project, Shenzhen Liande Automatic Equipment Co.Ltd(300545) convertible bond project, Unilumin Group Co.Ltd(300232) asset purchase project by issuing shares Sany Heavy Industry Co.Ltd(600031) M & A projects and CRRC industrial investment M & A projects.
Mr. Chen Yue: sponsor representative, master’s degree, now vice president of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in the following projects: Shenyang Machine Tool non-public offering project, China Railway Signal & Communication Corporation Limited(688009) H-share initial public offering project, Hengda new material initial public offering project, Baishan technology initial public offering project, Ningbo Shanshan Co.Ltd(600884) major asset restructuring project Hunan Mendale Hometextile Co.Ltd(002397) non public offering projects, etc.
Mr. Zhou Zhenxiang: certified public accountant, master’s degree, now senior manager of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in the following projects: China Railway Group Limited(601390) acquisition of the control right project of Beijing Hengtong innovation saimu Technology Co., Ltd., Sinotrans Limited(601598) share exchange, absorption and merger of air transport development and listing on the Shanghai Stock Exchange.
Mr. Jin Huaqiang: Master degree, senior manager of China Securities Co.Ltd(601066) securities investment banking business management committee. The projects involved include: Talkweb Information System Co.Ltd(002261) non-public offering project, CRRC mixed ownership reform project, Sany Heavy Industry Co.Ltd(600031) M & a project, Zhuzhou Tianqiao Crane Co.Ltd(002523) M & a project, Tinavi Medical Technologies Co.Ltd(688277) initial public offering project, etc. 3、 Basic information of the issuer (I) overview of the issuer
Company name: Tinavi Medical Technologies Co.Ltd(688277)
Registered address: room 206, 2f, building 1, Zone C, Dongsheng Science Park, No. 66, xixiaokou Road, Haidian District, Beijing
Date of establishment: October 22, 2010
Listing time: July 7, 2020
Registered capital: 41984684800 yuan
Place of listing: Shanghai Stock Exchange
Stock abbreviation Tinavi Medical Technologies Co.Ltd(688277)
Stock Code: 688277
Legal representative: Zhang Songgen
Secretary of the board of directors: Huang Junhui
Tel.: 010-82156660-8009
Internet address: https://cn.tinavi.com.
Main business: R & D, production, sales and service of orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024)
Type of this securities issuance: issuing shares to specific objects and listing
（2） Ownership structure
As of December 20, 2021, the share capital structure of the issuer is as follows:
Number of share classes (shares) proportion (%)
1、 Tradable shares with limited sales conditions 12074876028.76
1. State Shareholding–
2. Shareholding of state-owned legal person–
3. Other domestic shares 12044876028.69
Including: 4233056010.08 shares held by domestic non-state-owned legal persons
Shares held by domestic natural persons
